US Pays Moderna Inc COVID-19 Vaccine Developer Another $472m
July 27, 2020
7:29 am
The U.S. government’s Biomedical Advanced Research and Development Authority (BARDA) has paid Moderna Inc an additional $472 million to support the development of its novel coronavirus vaccine.
The U.S.-based drug maker said the additional funding will support its late-stage clinical development including the expanded Phase 3 study of Moderna’s vaccine candidate.
In April, Moderna had received $483 million from the U.S. federal agency that funds disease-fighting technology, when the experimental vaccine was in an early-stage trial conducted by the U.S. National Institutes of Health.
“Encouraged by the Phase 1 data, we …
